Loading...
Please wait, while we are loading the content...
Similar Documents
Molecular Targeted Positron Emission Tomography Imaging and Radionuclide Therapy of Pancreatic Ductal Adenocarcinoma
| Content Provider | MDPI |
|---|---|
| Author | Poels, Thomas T. Vuijk, Floris A. de Geus-Oei, Lioe-Fee Vahrmeijer, Alexander L. Oprea-Lager, Daniela E. Swijnenburg, Rutger-Jan |
| Copyright Year | 2021 |
| Description | Pancreatic ductal adenocarcinoma (PDAC) has an inauspicious prognosis, mainly due to difficulty in early detection of the disease by the current imaging modalities. The upcoming development of tumour-specific tracers provides an alternative solution for more accurate diagnostic imaging techniques for staging and therapy response monitoring. The future goal to strive for, in a patient with PDAC, should definitely be first to receive a diagnostic dose of an antibody labelled with a radionuclide and to subsequently receive a therapeutic dose of the same labelled antibody with curative intent. In the first part of this paper, we summarise the available evidence on tumour-targeted diagnostic tracers for molecular positron emission tomography (PET) imaging that have been tested in humans, together with their clinical indications. Tracers such as radiolabelled prostate-specific membrane antigen (PSMA)—in particular,$ ^{18}$F-labelled PSMA—already validated and successfully implemented in clinical practice for prostate cancer, also seem promising for PDAC. In the second part, we discuss the theranostic applications of these tumour-specific tracers. Although targeted radionuclide therapy is still in its infancy, lessons can already be learned from early publications focusing on dose fractioning and adding a radiosensitiser, such as gemcitabine. |
| Starting Page | 6164 |
| e-ISSN | 20726694 |
| DOI | 10.3390/cancers13246164 |
| Journal | Cancers |
| Issue Number | 24 |
| Volume Number | 13 |
| Language | English |
| Publisher | MDPI |
| Publisher Date | 2021-12-07 |
| Access Restriction | Open |
| Subject Keyword | Cancers Urology and Nephrology Pancreatic Ductal Adenocarcinoma Positron Emission Tomography Radionuclide Tumour Tracer |
| Content Type | Text |
| Resource Type | Article |